Stockreport

NeuroMetrix Reports Quell® Technology to be Used in NIH-Funded Trial Evaluating Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia

NeuroMetrix, Inc.  (NURO) 
Last neurometrix, inc. earnings: 4/20 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.neurometrix.com/investor-relations
PDF WOBURN, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology has been selected for use in a large, NIH-fund [Read more]